Siddiqui Ali, Cosgrove Natalie, Yan Linda H, Brandt Daniel, Janowski Raymond, Kalra Ankush, Zhan Tingting, Baron Todd H, Repici Allesandro, Taylor Linda Jo, Adler Douglas G
Jefferson University School of Medicine, Gastroenterology and Hepatology, Philadelphia, Pennsylvania, United States.
University of North Carolina, Gastroenterology and Hepatology, Chapel Hill, North Carolina, United States.
Endosc Int Open. 2017 Apr;5(4):E232-E238. doi: 10.1055/s-0043-102403.
Long-term data are limited regarding clinical outcomes of self-expanding metal stents as an alternative for surgery in the treatment of acute proximal MBO. The aim of this study was to compare the long-term outcomes of stenting to surgery for palliation in patients with incurable obstructive CRC for lesions proximal to the splenic flexure. Retrospective multicenter cohort study of obstructing proximal CRC patients with who underwent insertion of a SEMS (n = 69) or surgery (n = 36) from 1999 to 2014. The primary endpoint was relief of obstruction. Secondary endpoints included technical success, duration of hospital stay, early and late adverse events (AEs) and survival. Technical success was achieved in 62/69 (89.8 %) patients in the SEMS group and in 36 /36 (100 %) patients who underwent surgery ( = 0.09). In the SEMS group, 10 patients underwent stenting as a bridge to surgery and 59 underwent stent placement for palliation. Clinical relief was achieved in 78 % of patients with stenting and in 100 % of patients who underwent surgery ( < 0.001). Patients with SEMS had significantly less acute AEs compared to the surgery group (7.2 % vs. 30.5 %, = 0.003). Hospital mortality for the SEMS group was 0 % compared to 5.6 % in the surgery group ( = 0.11). Patients in the SEMS group had a significantly shorter median hospital stay (4 days) as compared to the surgery group (8 days) ( < 0.01). Maintenance of decompression without the recurrence of bowel obstruction until death or last follow-up was lower in the SEMS group (73.9 %) than the surgery group (97.3 %; = 0.003). SEMS placement was associated with higher long-term complication rates compared to surgery (21 % and 11 % = 0.27). Late SEMS AEs included occlusion (10 %), migration (5 %), and colonic ulcer (6 %). At 120 weeks, survival in the SEMS group was 5.6 % vs. 0 % in the surgery group ( = 0.8). Technical and clinical success associated with proximal colonic obstruction are higher with surgery when compared to SEMS, but surgery is associated with longer hospital stays and more early AEs. SEMS should be considered the initial mode of therapy in patients with acute proximal MBO and surgery should be reserved for SEMS failure, as surgery involves a high morbidity and mortality.
关于自膨式金属支架作为急性近端恶性大肠梗阻(MBO)手术替代治疗方法的临床结局,长期数据有限。本研究的目的是比较在无法治愈的梗阻性结直肠癌患者中,针对脾曲近端病变进行支架置入术与手术姑息治疗的长期结局。对1999年至2014年期间接受自膨式金属支架置入术(n = 69)或手术(n = 36)的近端梗阻性结直肠癌患者进行回顾性多中心队列研究。主要终点是梗阻缓解。次要终点包括技术成功率、住院时间、早期和晚期不良事件(AE)以及生存率。自膨式金属支架置入术组69例患者中有62例(89.8%)技术成功,手术组36例患者全部(100%)技术成功(P = 0.09)。在自膨式金属支架置入术组中,10例患者接受支架置入术作为手术的桥梁,59例患者接受支架置入术用于姑息治疗。支架置入术患者中有78%实现了临床缓解,手术患者中这一比例为100%(P < 0.001)。与手术组相比,自膨式金属支架置入术组患者的急性不良事件明显更少(7.2% 对30.5%,P = 0.003)。自膨式金属支架置入术组的医院死亡率为0%,而手术组为5.6%(P = 0.11)。与手术组相比,自膨式金属支架置入术组患者的中位住院时间明显更短(4天)(手术组为8天)(P < 0.01)。自膨式金属支架置入术组直至死亡或最后一次随访时无肠梗阻复发的减压维持率低于手术组(73.9% 对97.3%;P = 0.003)。与手术相比,自膨式金属支架置入术的长期并发症发生率更高(分别为21%和11%,P = 0.27)。自膨式金属支架置入术的晚期不良事件包括堵塞(10%)、移位(5%)和结肠溃疡(6%)。在120周时,自膨式金属支架置入术组的生存率为5.6%,手术组为0%(P = 0.8)。与自膨式金属支架置入术相比,手术治疗近端结肠梗阻的技术和临床成功率更高,但手术与更长的住院时间和更多的早期不良事件相关。对于急性近端MBO患者,应考虑将自膨式金属支架置入术作为初始治疗方式,手术应留作自膨式金属支架置入术失败时使用,因为手术涉及较高的发病率和死亡率。